UB Paderborn / Katalog / Suche / in CDI

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

Clinical infectious diseases, 2009-06, Vol.48 (12), p.1695-1703

2009

Link zum Volltext

Verfügbarkeit prüfen

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.561-566

2011

Link zum Volltext

Verfügbarkeit prüfen

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)

International journal of antimicrobial agents, 2011-07, Vol.38 (1), p.65-69

2011

Link zum Volltext

Verfügbarkeit prüfen

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene

Antimicrobial Agents and Chemotherapy, 2011-09, Vol.55 (9), p.4465-4468

2011

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.1065-1068

2013

Link zum Volltext

Verfügbarkeit prüfen

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.577-580

2014

Link zum Volltext

Verfügbarkeit prüfen

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.352-357

2012

Link zum Volltext

Verfügbarkeit prüfen

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2655-2659

2010

Link zum Volltext

Verfügbarkeit prüfen

Has Antifungal Susceptibility Testing Come of Age?

Clinical infectious diseases, 2002-10, Vol.35 (8), p.982-989

2002

Link zum Volltext

Verfügbarkeit prüfen

Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

Antimicrobial Agents and Chemotherapy, 2012-07, Vol.56 (7), p.3965-3968

2012

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of a Novel Broad-Spectrum Antifungal, E1210, Tested against Aspergillus spp. Determined by CLSI and EUCAST Broth Microdilution Methods

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5155-5158

2011

Link zum Volltext

Verfügbarkeit prüfen

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Clinical Microbiology Reviews, 2001-10, Vol.14 (4), p.643-658

2001

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial Resistance Trends and Outbreak Frequency in United States Hospitals

Clinical infectious diseases, 2004-01, Vol.38 (1), p.78-85

2004

Link zum Volltext

Verfügbarkeit prüfen

Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Antimicrobial Agents and Chemotherapy, 1998-07, Vol.42 (7), p.1762-1770

1998

Link zum Volltext

Verfügbarkeit prüfen

Multilaboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1543-1548

2011

Link zum Volltext

Verfügbarkeit prüfen

Clade-Specific Flucytosine Resistance Is Due to a Single Nucleotide Change in the FUR1 Gene of Candida albicans

Antimicrobial Agents and Chemotherapy, 2004-06, Vol.48 (6), p.2223-2227

2004

Link zum Volltext

Verfügbarkeit prüfen

Rapid Detection of Antibiotic-Resistant Organism Carriage for Infection Prevention

Clinical infectious diseases, 2013-06, Vol.56 (11), p.1614-1620

2013

Link zum Volltext

Verfügbarkeit prüfen

Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods

Antimicrobial Agents and Chemotherapy, 1998-05, Vol.42 (5), p.1207-1212

1998

Link zum Volltext

Verfügbarkeit prüfen

Haemophilus influenzae and Moraxella catarrhalis from Patients with Community-Acquired Respiratory Tract Infections: Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Antimicrobial Agents and Chemotherapy, 1999-02, Vol.43 (2), p.385-389

1999

Link zum Volltext

Verfügbarkeit prüfen

Flucytosine Resistance Is Restricted to a Single Genetic Clade of Candida albicans

Antimicrobial Agents and Chemotherapy, 2004-01, Vol.48 (1), p.262-266

2004

Link zum Volltext

Verfügbarkeit prüfen

Rationale for Reading Fluconazole MICs at 24 Hours Rather than 48 Hours When Testing Candida spp. by the CLSI M27-A2 Standard Method

Antimicrobial Agents and Chemotherapy, 2008-11, Vol.52 (11), p.4175-4177

2008

Link zum Volltext

Verfügbarkeit prüfen

Decreasing Prevalence of β-Lactamase Production among Respiratory Tract Isolates of Haemophilus influenzae in the United States

Antimicrobial Agents and Chemotherapy, 2005-06, Vol.49 (6), p.2561-2564

2005

Link zum Volltext

Verfügbarkeit prüfen

National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

Diagnostic microbiology and infectious disease, 1998-02, Vol.30 (2), p.121-129

1998

Link zum Volltext

Verfügbarkeit prüfen

Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998

Antimicrobial Agents and Chemotherapy, 2001-11, Vol.45 (11), p.3065-3069

2001

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Voriconazole Pharmacodynamics Using Time-Kill Methodology

Antimicrobial Agents and Chemotherapy, 2000-07, Vol.44 (7), p.1917-1920

2000

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Has Antifungal Susceptibility Testing Come of Age?

Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

In Vitro Activity of a Novel Broad-Spectrum Antifungal, E1210, Tested against Aspergillus spp. Determined by CLSI and EUCAST Broth Microdilution Methods

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Antimicrobial Resistance Trends and Outbreak Frequency in United States Hospitals

Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Multilaboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis

Clade-Specific Flucytosine Resistance Is Due to a Single Nucleotide Change in the FUR1 Gene of Candida albicans

Rapid Detection of Antibiotic-Resistant Organism Carriage for Infection Prevention

Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods

Haemophilus influenzae and Moraxella catarrhalis from Patients with Community-Acquired Respiratory Tract Infections: Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Flucytosine Resistance Is Restricted to a Single Genetic Clade of Candida albicans

Rationale for Reading Fluconazole MICs at 24 Hours Rather than 48 Hours When Testing Candida spp. by the CLSI M27-A2 Standard Method

Decreasing Prevalence of β-Lactamase Production among Respiratory Tract Isolates of Haemophilus influenzae in the United States

National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998

Evaluation of Voriconazole Pharmacodynamics Using Time-Kill Methodology

Aktive Filter

Suchergebnisse filtern